Peer Review Policy

1. Overview

All research articles, and most other article types, published in BRI journals undergo editorial assessment and peer review. Once a manuscript passes the initial checks, it will be assigned to at least two independent experts for peer review. Please note that BRI journals follow the standards of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.

2. Type of peer review

BRI operates double-blind peer review.

3. Peer Review Process

The Journal Editorial Office will perform an initial check of manuscript’s suitability upon receipt and other requirements. The prime purpose is to decide whether to send a paper for peer review and to give a rapid decision on those that are not.

It is then an editor will select appropriate experts for peer review.

Selection of Reviewers: BRI will find appropriate experts to review the manuscripts. Potential reviewers will be personally contacted by the editorial staff to seek expression of interest to review the paper. The email will contain the details of the manuscript title and the abstract. The reviewers will be asked to disclose conflict of interest. If the reviewers agree to review, and if there is no potential conflict of interest, they will receive the official invitation from the journal containing the link to access the manuscript.

Peer Review and Reviewer Responsibilities: The reviewers will remain anonymous. Reviewers are expected to keep the manuscript confidential, provide an unbiased scientific opinion of the manuscript and declare any conflict of interest. Also, reviewers are expected to submit their comments within the indicated time frame.

To provide an assessment of the various aspects of a manuscript we ask reviewers the following types of questions:

Criteria for Assessing Articles:

• Does the manuscript require language editing?

• Does the abstract convey the major theme of the paper?

• Does the introduction describe the rationale for the study in the context of the available literature?

• Does the article comprehensively and critically evaluate an existing problem in the context of the available literature?

• Where relevant, have appropriate ethics approval and informed consent been obtained?

• Are the methods adequately described?

• Is the number of samples, number of repeats, equipment and chemicals used clearly mentioned?

• Is the catalogue number of antibodies mentioned?

• Are statistical methods clearly stated?

• Is the discussion well-balanced in light of the available literature and the research findings?

• Are any conflicts of interest stated?

• Experiments including patient or animal data should properly be documented. Most journals require ethical approval by the author’s host organization. For more information about Editorial Policies.

Editorial decision: Based on the comments of the reviewers, a decision will be made either to accept the manuscript without any changes, give authors an opportunity to revise and resubmit, or reject. The corresponding author will be notified of the decision.

If the authors choose to revise and resubmit, the manuscript will be evaluated by the original reviewers or the editor-in-chief to verify if the original comments of the reviewers have been adequately addressed. If the authors have adequately addressed the original comments, the reviewers are not allowed to raise new comments. Depending upon the evaluation, the manuscript will be either accepted or returned to the authors for further clarification. If the paper is accepted, it will be published online. If rejected, authors may appeal this decision by sending an e-mail to the journal’s Editorial Office. The appeal must provide a detailed justification, including point-by-point responses to the reviewers' and/or Editor's comments. The Managing Editor of the journal will forward the manuscript and related information (including the identities of the referees) to the Editor-in-Chief, Associate Editor, or Editorial Board member. The academic editor being consulted will be asked to give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage is final and cannot be reversed.

Each published article will be assigned a DOI, deposited with Crossref.

4. Privacy and Confidentiality

In BRI journals, manuscripts must be reviewed with due respect for authors' confidentiality. In submitting their manuscripts for review, authors entrust editors with the results of their scientific work and creative effort, on which their reputation and career may depend. This means you cannot share the contents of the manuscript with anyone without prior authorization from the editor. Since peer review is confidential, you also must not share information about the review with anyone without permission from the editors and authors.

Information concerning the manuscript (including the content of the manuscript, the status of the review process, peer review comments, and editorial decisions, etc.) must not be disclosed by the editor to anyone other than the author and reviewers.

Reviewers and editors must respect the rights of authors, and must not publicly discuss the authors' work or misappropriate their ideas before the manuscript is published. Without the permission of the editor, reviewers are not allowed to make copies of the manuscripts and are prohibited from sharing the manuscript with others.

5. Conflict of Interest in Reviewing Process

Reviewers should declare their conflicts of interest and recuse themselves from the peer-review process if a conflict exists. For details, please refer to ICMJE.

BRI requires editorial staff or editors not be involved in processing their own academic work.

Guest Editors should not hold conflicts of interest with authors whose work they are assessing (e.g., from the same institution or collaborate closely). In this case, the Editor-in-Chief or a suitable Editorial Board member will make final acceptance decisions for submitted papers.

6. Publication Ethics Statement

It is essential that all who participate in producing the journal, who conduct themselves as authors, reviewers and editors, strictly adhere to the highest level of professional ethical standards. By submitting a manuscript to this journal, each author explicitly confirms that the manuscript meets the highest ethical standards from the author and coauthors including proper statistical investigations and thorough ethical reviews by the data owning organisations.

BRI follow the best practices such as those outlined by these organizations:

Committee on Publication Ethics (COPE)

International Committee of Medical Journal Editors (ICMJE)

Council of Scientific Editors (CSE)

National Information Standards Organization (NISO)

National Institutes of Health (NIH)

World Association of Medical Editors (WAME)

World Medical Association (WMA)